Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 358 | 438 | 351 | 0 | 0 |
| Gross Profit | 358 | 438 | 351 | N/A | N/A |
| Operating Expenses | 21,265 | 19,815 | 22,828 | 24,881 | 27,236 |
| Operating Income | -20,907 | -19,377 | -22,477 | -24,881 | -27,236 |
| Other Income | 994 | 4,042 | 30,681 | 5,026 | 59,918 |
| Pre-tax Income | -19,913 | -15,335 | 8,204 | -19,855 | 32,682 |
| Net Income Continuous | -19,913 | -15,335 | 8,204 | -19,855 | 32,682 |
| Net Income | $-19,913 | $-15,335 | $8,204 | $-19,855 | $32,682 |
| EPS Basic Total Ops | -2.08 | -1.79 | 0.94 | -2.27 | 3.76 |
| EPS Basic Continuous Ops | -2.08 | -1.79 | 0.94 | -2.27 | 3.76 |
| EPS Diluted Total Ops | -2.08 | -1.78 | 0.94 | -2.27 | 3.75 |
| EPS Diluted Continuous Ops | -2.08 | -1.78 | 0.94 | -2.27 | 3.75 |
| EPS Diluted Before Non-Recurring Items | -2.08 | -1.89 | 0.94 | -2.27 | -2.24 |
| EBITDA(a) | $-20,126 | $-18,423 | $-21,433 | $-23,822 | $-26,160 |